Exploiting the Glycome for Cancer Therapeutics

Article   Jun 14, 2018 | by Joanna Owens, PhD, Freelance Writer and Editor, UK

 
Exploiting the Glycome for Cancer Therapeutics
 
 
 

RELATED ARTICLES

Cisplatin Efficacy: The Importance of Measuring Uptake in Cancer Cells

Article

Although cisplatin is clinically proven to combat numerous human cancers – bladder, head and neck, lung, ovarian, testicular – resistance to treatment remains a key challenge, and cisplatin patients can often relapse. Having the ability to determine the cellular uptake of cisplatin is key to developing novel strategies to increase tumor cell sensitivity to cisplatin.

READ MORE

How Are We Developing Vaccines for the Future?

Article

This article highlights the types of vaccine, trends in developing future vaccines and discusses new delivery methods and strategies to help advance our understanding of the immune system.

READ MORE

Mass Spectrometry in Biopharmaceutical Discovery

Article

Biotherapeutics now makes up 25% of new drugs approvals. Their efficacy and safety are highly dependent on their structures, which are complex, heterogeneous and subject to modification. Advances in mass spectrometry are allowing more information on higher order structure and new imaging techniques are even providing insights into how biological drugs behave in vivo.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy